| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780363 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
In this population-based prospective cohort study, ever users of LNG-IUS had a strongly reduced risk of ovarian and endometrial cancer compared to never users, with no increased risk of breast cancer.
Keywords
LNG-IUSSIRLevonorgestrel-releasing intrauterine systemstandard deviationEpidemiologyRelative riskICDPerson-yearsbody mass indexBMIInternational Classification of Diseasesconfidence intervalLevonorgestrelProspective cohort studyOvarian neoplasmsUterine neoplasmsBreast neoplasmsstandardized incidence ratioIntrauterine deviceoral contraceptivesHormonal contraceptives
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mie Jareid, Jean-Christophe Thalabard, Morten Aarflot, Hege M. Bøvelstad, Eiliv Lund, Tonje Braaten,